APO RESEARCH · REPORT
Organ-on-Chip
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Product & engineering
Understand the product.
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Selected research
Market Outlook & Growth Opportunities
Global Organ-on-Chip Market Outlook and Growth Opportunities 2026
Market perspective
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Global Organ-on-Chip key players include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, etc. Global top five manufacturers hold a share about 55%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
Read the full market overview
In terms of product, Liver-on-a-chip is the largest segment, with a share about 30%. And in terms of application, the largest application is Pharmaceutical & Biotechnology Companies, followed by Academic & Research Institutes.
This report provides an overview of the global Organ-on-Chip market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Organ-on-Chip and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Organ-on-Chip sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Organ-on-Chip market size, projected growth trends, production technologies, key applications, and end-use industries.
Organ-on-Chip Segment by Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Organ-on-Chip Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Others
Organ-on-Chip Segment by End Users
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Cosmetics Industry
Other End Users
Organ-on-Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Organ-on-Chip status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Organ-on-Chip market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Organ-on-Chip significant trends, drivers, influence factors in global and regions.
6. To analyze Organ-on-Chip competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ-on-Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organ-on-Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ-on-Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Organ-on-Chip market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Organ-on-Chip industry.
Chapter 3: Detailed analysis of Organ-on-Chip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Organ-on-Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Organ-on-Chip in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Others
Applications
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Cosmetics Industry
- Other End Users
Companies covered
- Emulate
- TissUse
- Hesperos
- CN Bio Innovations
- Tara Biosystems
- Draper Laboratory
- Mimetas
- Nortis
- Micronit Microtechnologies B.V.
- Kirkstall
- Cherry Biotech SAS
- Else Kooi Laboratory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Organ-on-Chip Sales Value (2021-2032)
- 1.2.2 Global Organ-on-Chip Sales Volume (2021-2032)
- 1.2.3 Global Organ-on-Chip Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Organ-on-Chip Market Dynamics
- 2.1 Organ-on-Chip Industry Trends
- 2.2 Organ-on-Chip Industry Drivers
- 2.3 Organ-on-Chip Industry Opportunities and Challenges
- 2.4 Organ-on-Chip Industry Restraints
3 Organ-on-Chip Market by Company
- 3.1 Global Organ-on-Chip Company Revenue Ranking in 2025
- 3.2 Global Organ-on-Chip Revenue by Company (2021-2026)
- 3.3 Global Organ-on-Chip Sales Volume by Company (2021-2026)
- 3.4 Global Organ-on-Chip Average Price by Company (2021-2026)
- 3.5 Global Organ-on-Chip Company Ranking (2024-2026)
- 3.6 Global Organ-on-Chip Company Manufacturing Base and Headquarters
- 3.7 Global Organ-on-Chip Company Product Type and Application
- 3.8 Global Organ-on-Chip Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Organ-on-Chip Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Organ-on-Chip Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Organ-on-Chip Market by Type
- 4.1 Organ-on-Chip Type Introduction
- 4.1.1 Brain-on-a-chip
- 4.1.2 Liver-on-a-chip
- 4.1.3 Kidney-on-a-chip
- 4.1.4 Lung-on-a-chip
- 4.1.5 Heart-on-a-chip
- 4.1.6 Intestine-on-a-chip
- 4.1.7 Others
- 4.2 Global Organ-on-Chip Sales Volume by Type
- 4.2.1 Global Organ-on-Chip Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Organ-on-Chip Sales Volume by Type (2021-2032)
- 4.2.3 Global Organ-on-Chip Sales Volume Share by Type (2021-2032)
- 4.3 Global Organ-on-Chip Sales Value by Type
- 4.3.1 Global Organ-on-Chip Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Organ-on-Chip Sales Value by Type (2021-2032)
- 4.3.3 Global Organ-on-Chip Sales Value Share by Type (2021-2032)
5 Organ-on-Chip Market by Application
- 5.1 Organ-on-Chip Application Introduction
- 5.1.1 Pharmaceutical and Biotechnology Companies
- 5.1.2 Academic and Research Institutes
- 5.1.3 Cosmetics Industry
- 5.1.4 Other End Users
- 5.2 Global Organ-on-Chip Sales Volume by Application
- 5.2.1 Global Organ-on-Chip Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Organ-on-Chip Sales Volume by Application (2021-2032)
- 5.2.3 Global Organ-on-Chip Sales Volume Share by Application (2021-2032)
- 5.3 Global Organ-on-Chip Sales Value by Application
- 5.3.1 Global Organ-on-Chip Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Organ-on-Chip Sales Value by Application (2021-2032)
- 5.3.3 Global Organ-on-Chip Sales Value Share by Application (2021-2032)
6 Organ-on-Chip Regional Sales and Value Analysis
- 6.1 Global Organ-on-Chip Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Organ-on-Chip Sales by Region (2021-2032)
- 6.2.1 Global Organ-on-Chip Sales by Region: 2021-2026
- 6.2.2 Global Organ-on-Chip Sales by Region (2027-2032)
- 6.3 Global Organ-on-Chip Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Organ-on-Chip Sales Value by Region (2021-2032)
- 6.4.1 Global Organ-on-Chip Sales Value by Region: 2021-2026
- 6.4.2 Global Organ-on-Chip Sales Value by Region (2027-2032)
- 6.5 Global Organ-on-Chip Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Organ-on-Chip Sales Value (2021-2032)
- 6.6.2 North America Organ-on-Chip Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Organ-on-Chip Sales Value (2021-2032)
- 6.7.2 Europe Organ-on-Chip Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Organ-on-Chip Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Organ-on-Chip Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Organ-on-Chip Sales Value (2021-2032)
- 6.9.2 South America Organ-on-Chip Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Organ-on-Chip Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Organ-on-Chip Sales Value Share by Country, 2025 VS 2032
7 Organ-on-Chip Country-level Sales and Value Analysis
- 7.1 Global Organ-on-Chip Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Organ-on-Chip Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Organ-on-Chip Sales by Country (2021-2032)
- 7.3.1 Global Organ-on-Chip Sales by Country (2021-2026)
- 7.3.2 Global Organ-on-Chip Sales by Country (2027-2032)
- 7.4 Global Organ-on-Chip Sales Value by Country (2021-2032)
- 7.4.1 Global Organ-on-Chip Sales Value by Country (2021-2026)
- 7.4.2 Global Organ-on-Chip Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.9.2 France Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.16.2 China Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.19.2 India Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Organ-on-Chip Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Organ-on-Chip Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Organ-on-Chip Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Emulate
- 8.1.1 Emulate Company Information
- 8.1.2 Emulate Business Overview
- 8.1.3 Emulate Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Emulate Organ-on-Chip Product Portfolio
- 8.1.5 Emulate Recent Developments
- 8.2 TissUse
- 8.2.1 TissUse Company Information
- 8.2.2 TissUse Business Overview
- 8.2.3 TissUse Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.2.4 TissUse Organ-on-Chip Product Portfolio
- 8.2.5 TissUse Recent Developments
- 8.3 Hesperos
- 8.3.1 Hesperos Company Information
- 8.3.2 Hesperos Business Overview
- 8.3.3 Hesperos Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Hesperos Organ-on-Chip Product Portfolio
- 8.3.5 Hesperos Recent Developments
- 8.4 CN Bio Innovations
- 8.4.1 CN Bio Innovations Company Information
- 8.4.2 CN Bio Innovations Business Overview
- 8.4.3 CN Bio Innovations Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.4.4 CN Bio Innovations Organ-on-Chip Product Portfolio
- 8.4.5 CN Bio Innovations Recent Developments
- 8.5 Tara Biosystems
- 8.5.1 Tara Biosystems Company Information
- 8.5.2 Tara Biosystems Business Overview
- 8.5.3 Tara Biosystems Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Tara Biosystems Organ-on-Chip Product Portfolio
- 8.5.5 Tara Biosystems Recent Developments
- 8.6 Draper Laboratory
- 8.6.1 Draper Laboratory Company Information
- 8.6.2 Draper Laboratory Business Overview
- 8.6.3 Draper Laboratory Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Draper Laboratory Organ-on-Chip Product Portfolio
- 8.6.5 Draper Laboratory Recent Developments
- 8.7 Mimetas
- 8.7.1 Mimetas Company Information
- 8.7.2 Mimetas Business Overview
- 8.7.3 Mimetas Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Mimetas Organ-on-Chip Product Portfolio
- 8.7.5 Mimetas Recent Developments
- 8.8 Nortis
- 8.8.1 Nortis Company Information
- 8.8.2 Nortis Business Overview
- 8.8.3 Nortis Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Nortis Organ-on-Chip Product Portfolio
- 8.8.5 Nortis Recent Developments
- 8.9 Micronit Microtechnologies B.V.
- 8.9.1 Micronit Microtechnologies B.V. Company Information
- 8.9.2 Micronit Microtechnologies B.V. Business Overview
- 8.9.3 Micronit Microtechnologies B.V. Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Micronit Microtechnologies B.V. Organ-on-Chip Product Portfolio
- 8.9.5 Micronit Microtechnologies B.V. Recent Developments
- 8.10 Kirkstall
- 8.10.1 Kirkstall Company Information
- 8.10.2 Kirkstall Business Overview
- 8.10.3 Kirkstall Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Kirkstall Organ-on-Chip Product Portfolio
- 8.10.5 Kirkstall Recent Developments
- 8.11 Cherry Biotech SAS
- 8.11.1 Cherry Biotech SAS Company Information
- 8.11.2 Cherry Biotech SAS Business Overview
- 8.11.3 Cherry Biotech SAS Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Cherry Biotech SAS Organ-on-Chip Product Portfolio
- 8.11.5 Cherry Biotech SAS Recent Developments
- 8.12 Else Kooi Laboratory
- 8.12.1 Else Kooi Laboratory Company Information
- 8.12.2 Else Kooi Laboratory Business Overview
- 8.12.3 Else Kooi Laboratory Organ-on-Chip Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Else Kooi Laboratory Organ-on-Chip Product Portfolio
- 8.12.5 Else Kooi Laboratory Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Organ-on-Chip Value Chain Analysis
- 9.1.1 Organ-on-Chip Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Organ-on-Chip Sales Mode & Process
- 9.2 Organ-on-Chip Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Organ-on-Chip Distributors
- 9.2.3 Organ-on-Chip Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst